42
Participants
Start Date
February 5, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Dexamethasone
Dexamethasone will be administered for 10 days. For the first 48 hours, dexamethasone will be given iv. After 48 hours, a switch to oral dexamethasone (same dosage) is permitted at the discretion of the study physician.
Ribavirin
Ribavirin treatment will be administered iv for 10 days, as recommended in the Nigeria Centre for Disease Control and Prevention National Guidelines for LF Case Management.
RECRUITING
Irrua Specialist Teaching Hospital, Irrua
Bernhard Nocht Institute for Tropical Medicine
OTHER_GOV